Harvard Business Review November 14, 2016
Alexander L. Fogel and Joseph C. Kvedar

Businesses that are serious about reducing health care costs — and improving the health and well-being of their employees — should take a serious look at digital therapeutics, which have the potential to provide effective, low-cost ways to prevent and treat chronic diseases and their consequences. Digital therapeutics are technology-based solutions that have a clinical impact on disease comparable to that of a drug. They primarily use consumer-grade technology such as mobile devices, wearable sensors, big data analytics, and behavioral science and can be delivered through web browsers, apps, or in conjunction with medical devices. They can also be deployed in real time and at scale, which is critical for intervention in chronic diseases.

These broad applications now include artificial-intelligence-driven...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Analytics, Apps, Big Data, Employer, Health IT, Health System / Hospital, Medicaid, Medicare, Medicare Advantage, mHealth, Patient / Consumer, Payer, Physician, Population Health Mgmt, Pricing / Spending, Primary care, Provider, RCM (Revenue Cycle Mgmt), Self-insured, Telehealth, Wearables
15 defining healthcare trends and challenges
How Insurance Claim Denials Harm Patients’ Health, Finances
Rural leadership conference day two roundup
Sounding the Alarm on the Human Cost of Medical Debt
Can AI predict the next pandemic? A new study says yes

Share This Article